This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Huang, Y. Articles by Waxman, S. Search for Related Content PubMed PubMed Citation Articles by Huang, Y. Articles by Waxman, S.

Regrowth of 5-Fluorouracil-treated Human Colon Cancer Cells Is Prevented by the Combination of Interferon , Indomethacin, and Phenylbutyrate¹

Rochelle Belfer Chemotherapy Foundation Laboratory, Division of Medical Oncology [Y. H., S. W.] and, Immunobiology Center, Mount Sinai School of Medicine [C. M. H.], New York, New York 10029

We previously reported that phenylbutyrate (PB), a differentiation agent, retarded the regrowth of fluoropyrimidine-treated HT29 cells to a greater extent in a well-differentiated subclone as compared with a poorly differentiated subclone (Y. Huang and S. Waxman, Clin. Cancer Res., 4: 2503–2509, 1998). To extend these results and to overcome the known heterogeneity of human colon carcinoma (HCC) cells, the effect of cytostatic agents reported to inhibit HCC growth [IFN- and IFN-, indomethacin, and PB alone or in combination] on clonogenicity and HCCs recovery from 5-fluorouracil (FUra) treatment was studied in eight different HCCs. IFN- proved to be ineffective in all eight HCCs, whereas IFN- induced marked growth inhibition in four HCCs that expressed wild-type K-ras. Despite large differences in HCC response to the other individual agents, strong growth inhibition was observed when PB was added in combination with indomethacin. The inhibition was even more pronounced when IFN- was included in the regimen. Most importantly, after treatment with the combination of three agents, the clonogenic potential was severely inhibited (92–100%) in the IFN--sensitive cell lines, whereas in the IFN--insensitive cell lines, comparable loss of clonogenecity was obtained when the cells were pretreated with FUra. As known and described in detail, the three cytostatic agents inhibit different processes necessary for cell growth, thus requiring the cells to repair multiple pathways to restore growth. The induction of STAT1 DNA binding activity by IFN- and p21^WAF1 by PB, alone or in combination, correlated with growth inhibition and loss of clonogenicity. The finding that the readily reversible growth inhibition and decrease in clonogenicity of FUra-treated HCC are prolonged by subsequent treatment with the three cytostatic agents in all HCCs may be of clinical importance because FUra continues to be the most widely used cytotoxic agent in the treatment of colon carcinoma.

This article has been cited by other articles:

				C. Leonetti, M. Scarsella, G. Zupi, W. Zoli, D. Amadori, L. Medri, F. Fabbri, M. Rosetti, P. Ulivi, L. Cecconetto, et al. Efficacy of a nitric oxide-releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts. Mol. Cancer Ther., April 1, 2006; 5(4): 919 - 926. [Abstract] [Full Text] [PDF]

				M. R. Acharya, A. Sparreboom, J. Venitz, and W. D. Figg Rational Development of Histone Deacetylase Inhibitors as Anticancer Agents: A Review Mol. Pharmacol., October 1, 2005; 68(4): 917 - 932. [Abstract] [Full Text] [PDF]

				M. J. Aleman, M. P. DeYoung, M. Tress, P. Keating, G. W. Perry, and R. Narayanan Inhibition of Single Minded 2 gene expression mediates tumor-selective apoptosis and differentiation in human colon cancer cells PNAS, September 6, 2005; 102(36): 12765 - 12770. [Abstract] [Full Text] [PDF]

				X.-N. Li, S. Parikh, Q. Shu, H.-L. Jung, C.-W. Chow, L. Perlaky, H.-C. E. Leung, J. Su, S. Blaney, and C. C. Lau Phenylbutyrate and Phenylacetate Induce Differentiation and Inhibit Proliferation of Human Medulloblastoma Cells Clin. Cancer Res., February 1, 2004; 10(3): 1150 - 1159. [Abstract] [Full Text] [PDF]

				L. Klampfer, J. Huang, G. Corner, J. Mariadason, D. Arango, T. Sasazuki, S. Shirasawa, and L. Augenlicht Oncogenic Ki-Ras Inhibits the Expression of Interferon-responsive Genes through Inhibition of STAT1 and STAT2 Expression J. Biol. Chem., November 21, 2003; 278(47): 46278 - 46287. [Abstract] [Full Text] [PDF]